FindTrial
Sign In

Can Periurethral injection of autologous platelet-rich plasma improve female genuine stress Incontinence?

Effect of periurethral injection of autologous platelet-rich plasma in female genuine stress incontinence- A single arm interventional pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052208
Enrollment
97
Registered
2023-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N393- Stress incontinence (female) (male)

Interventions

Intervention1: Platelet rich plasma: 5 millilitres of Platelet-rich plasma extracted from patients own blood will be injected periurethrally at 5 sites, 1 ml at each site. Control Intervention1: Nil:

Sponsors

Multi-Disciplinary Research Unit
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All females >18 years of age with Genuine Stress Incontinence will be included. They should have normal platelet count.

Exclusion criteria

Exclusion criteria: 1. Urge incontinence 2.Urinary tract infection 3.Thrombocytopenia 4.Anti-coagulant users

Design outcomes

Primary

MeasureTime frame
Improvement in symptom of leakage of urine, ALPP,GRA.Timepoint: Improvement in symptoms at 4 weeks, 8 weeks ,12 weeks and 16 weeks—

Secondary

MeasureTime frame
Improvement in VAS scoreTimepoint: After 6 months of last injection—

Countries

India

Contacts

Public ContactDr Archana Sinha

IGIMS,Patna

drarchanasinha35@gmail.com9661599099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026